Rebamipide 2% Ophthalmic Suspension for the Treatment of Allergic Keratoconjunctivitis: A Hospital Based Study
Background: The aim of this study was to evaluate the effectiveness of Rebamipide 2% ophthalmic suspension in the treatment of Allergic Keratoconjunctivitis. Rebamipide 2% ophthalmic suspension has shown to be advantageous for the treatment of dry eye and an improvement of ocular allergic conditions...
Saved in:
| Main Authors: | Munish Dhawan, Tania Hans, Baltej Singh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2016-04-01
|
| Series: | Delhi Journal of Ophthalmology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.7869/djo.183 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of Topical Cyclosporine 0.05% in Allergic Conjunctivitis
by: Sonali Bhalla, et al.
Published: (2015-01-01) -
The allergic eye
by: André Marais
Published: (2016-03-01) -
Conjunctival Cysts in a Case of Severe Vernal Keratoconjunctivitis – A Rare Finding
by: Rajwinder Kaur, et al.
Published: (2025-01-01) -
Use of explainable AI on slit-lamp images of anterior surface of eyes to diagnose allergic conjunctival diseases
by: Michiko Yonehara, et al.
Published: (2025-01-01) -
Topical treatment options for allergic conjunctivitis
by: Sumari Davis
Published: (2015-07-01)